Tips for Vaccination of Nine-valent Human Papillomavirus in Zhenjiang Kangrui Hospital

1. Very common adverse reactions of vaccine at inoculation site:

Local pain, swelling and erythema in turn; The common inoculation sites are itching and induration. General fever, headache, dizziness, fatigue, muscle pain, joint pain, gastrointestinal symptoms.

2. Applicable population of 2.HPV vaccine:

Priority is given to recommending women aged 9-26, especially those before 17 to be vaccinated with human papillomavirus; At the same time, it is recommended that eligible women aged 27 ~ 45 be vaccinated with HPV vaccine. Vaccination against human papillomavirus is recommended regardless of asexual behavior or previous exposure to human papillomavirus. If you are pregnant, you can postpone the vaccination of human papillomavirus until breastfeeding.

3. Can I get HPV vaccine after cervical lesion treatment?

It is recommended that school-age women who have undergone HSIL ablation or resection in the past be vaccinated with HPV vaccine. Whether HPV vaccine benefits after cervical cancer treatment needs further study and confirmation.

4. Suggestions for special people:

People with low immune function include: HIV-infected people; Patients with autoimmune diseases, such as autoimmune inflammatory rheumatism and Hashimoto's thyroiditis; Hemodialysis patients with obesity, diabetes and renal failure; For patients who take immunosuppressants for a long time after organ/bone marrow transplantation, it is recommended that school-age women be vaccinated with HPV vaccine in the above population.

5. Precautions for vaccination of human papillomavirus:

① Cervical cancer screening should be carried out after vaccination with human papillomavirus vaccine;

(2) HPV vaccine is a preventive vaccine, which cannot treat infected human papillomavirus and related diseases, prevent all types of human papillomavirus infection, and prevent human papillomavirus infection from progressing into diseases;

③ A few cervical cancers may have nothing to do with HPV infection, especially the special type of cancer with negative HPV;

④ Since the advent of HPV vaccine in 2006, the long-term follow-up study of 14 years has confirmed the protective efficacy of HPV vaccine. At present, there is no evidence that HPV vaccine has lifelong protection effect.